These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 32455867

  • 21. Ephrin-B2 reverse signaling regulates progression and lymph node metastasis of oral squamous cell carcinoma.
    Sasabe E, Tomomura A, Tomita R, Sento S, Kitamura N, Yamamoto T.
    PLoS One; 2017; 12(11):e0188965. PubMed ID: 29190834
    [Abstract] [Full Text] [Related]

  • 22. Zinc finger AN1-type containing 4 is a novel marker for predicting metastasis and poor prognosis in oral squamous cell carcinoma.
    Kurihara-Shimomura M, Sasahira T, Nakamura H, Nakashima C, Kuniyasu H, Kirita T.
    J Clin Pathol; 2018 May; 71(5):436-441. PubMed ID: 29074611
    [Abstract] [Full Text] [Related]

  • 23. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M, Wang C, Chen W, Mao C, Wang J.
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [Abstract] [Full Text] [Related]

  • 24. Collagen Triple Helix Repeat Containing-1 (CTHRC1) Expression in Oral Squamous Cell Carcinoma (OSCC): Prognostic Value and Clinico-Pathological Implications.
    Lee CE, Vincent-Chong VK, Ramanathan A, Kallarakkal TG, Karen-Ng LP, Ghani WM, Rahman ZA, Ismail SM, Abraham MT, Tay KK, Mustafa WM, Cheong SC, Zain RB.
    Int J Med Sci; 2015 Apr; 12(12):937-45. PubMed ID: 26664254
    [Abstract] [Full Text] [Related]

  • 25. Urokinase plasminogen activator receptor (uPAR) and plasminogen activator inhibitor-1 (PAI-1) are potential predictive biomarkers in early stage oral squamous cell carcinomas (OSCC).
    Magnussen S, Rikardsen OG, Hadler-Olsen E, Uhlin-Hansen L, Steigen SE, Svineng G.
    PLoS One; 2014 Apr; 9(7):e101895. PubMed ID: 24999729
    [Abstract] [Full Text] [Related]

  • 26. Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells.
    Wang SH, Chang JS, Hsiao JR, Yen YC, Jiang SS, Liu SH, Chen YL, Shen YY, Chang JY, Chen YW.
    Oncogene; 2017 Mar; 36(11):1503-1515. PubMed ID: 27593938
    [Abstract] [Full Text] [Related]

  • 27. Insulin-like growth factor II mRNA-binding protein 3 expression promotes tumor formation and invasion and predicts poor prognosis in oral squamous cell carcinoma.
    Lin CY, Chen ST, Jeng YM, Yeh CC, Chou HY, Deng YT, Chang CC, Kuo MY.
    J Oral Pathol Med; 2011 Oct; 40(9):699-705. PubMed ID: 23647076
    [Abstract] [Full Text] [Related]

  • 28. ASC contributes to metastasis of oral cavity squamous cell carcinoma.
    Wu CS, Chang KP, OuYang CN, Kao HK, Hsueh C, Chen LC, Cheng HY, Liang Y, Liou W, Liang CL, Chang YS.
    Oncotarget; 2016 Aug 02; 7(31):50074-50085. PubMed ID: 27367024
    [Abstract] [Full Text] [Related]

  • 29. High mobility group box-1-inducible melanoma inhibitory activity is associated with nodal metastasis and lymphangiogenesis in oral squamous cell carcinoma.
    Sasahira T, Kirita T, Oue N, Bhawal UK, Yamamoto K, Fujii K, Ohmori H, Luo Y, Yasui W, Bosserhoff AK, Kuniyasu H.
    Cancer Sci; 2008 Sep 02; 99(9):1806-12. PubMed ID: 18616526
    [Abstract] [Full Text] [Related]

  • 30. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
    Dai J, Wei W.
    Arch Oral Biol; 2017 Nov 02; 83():40-46. PubMed ID: 28697409
    [Abstract] [Full Text] [Related]

  • 31. Regulation of proliferation and cell cycle by protein regulator of cytokinesis 1 in oral squamous cell carcinoma.
    Wu F, Shi X, Zhang R, Tian Y, Wang X, Wei C, Li D, Li X, Kong X, Liu Y, Guo W, Guo Y, Zhou H.
    Cell Death Dis; 2018 May 01; 9(5):564. PubMed ID: 29752448
    [Abstract] [Full Text] [Related]

  • 32. Malic Enzyme 1 Is Associated with Tumor Budding in Oral Squamous Cell Carcinomas.
    Nakashima C, Kirita T, Yamamoto K, Mori S, Luo Y, Sasaki T, Fujii K, Ohmori H, Kawahara I, Mori T, Goto K, Kishi S, Fujiwara-Tani R, Kuniyasu H.
    Int J Mol Sci; 2020 Sep 28; 21(19):. PubMed ID: 32998265
    [Abstract] [Full Text] [Related]

  • 33. Overexpression of c-fos promotes cell invasion and migration via CD44 pathway in oral squamous cell carcinoma.
    Dong C, Ye DX, Zhang WB, Pan HY, Zhang ZY, Zhang L.
    J Oral Pathol Med; 2015 May 28; 44(5):353-60. PubMed ID: 25482572
    [Abstract] [Full Text] [Related]

  • 34. Expression of growth differentiation factor 15 is positively correlated with histopathological malignant grade and in vitro cell proliferation in oral squamous cell carcinoma.
    Zhang L, Yang X, Pan HY, Zhou XJ, Li J, Chen WT, Zhong LP, Zhang ZY.
    Oral Oncol; 2009 Jul 28; 45(7):627-32. PubMed ID: 18805046
    [Abstract] [Full Text] [Related]

  • 35. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
    Bufalino A, Cervigne NK, de Oliveira CE, Fonseca FP, Rodrigues PC, Macedo CC, Sobral LM, Miguel MC, Lopes MA, Paes Leme AF, Lambert DW, Salo TA, Kowalski LP, Graner E, Coletta RD.
    PLoS One; 2015 Jul 28; 10(8):e0136599. PubMed ID: 26317418
    [Abstract] [Full Text] [Related]

  • 36. TMEM207 hinders the tumour suppressor function of WWOX in oral squamous cell carcinoma.
    Bunai K, Okubo H, Hano K, Inoue K, Kito Y, Saigo C, Shibata T, Takeuchi T.
    J Cell Mol Med; 2018 Feb 28; 22(2):1026-1033. PubMed ID: 29164763
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.